Shockwave For Diabetic Foot Ulcer - ODM Product
From my workshop to your clinic, the Shockwave For Diabetic Foot Ulcer is engineered for fast healing and reduced hospital visits. I offer ODM options to tailor the device to your brand and workflow—customizable casing, firmware, treatment protocols, and accessory kits. Our product features: adjustable energy flux density, pulse rate, clinically validated healing times, portable and easy to operate, safe for outpatient use, sterile disposable applicators, robust safety features, data logging, and remote service. I know what buyers want: compatibility with existing wound care protocols, regulatory approvals (CE, ISO), reliable after-sales support, competitive pricing, and quick lead times. This product helps you differentiate with your customers, expands revenue streams, and optimizes procurement with bulk orders. I handle every step of the ODM process—design, manufacturing, QA, packaging, and logistics—so you can launch quickly.
Shockwave For Diabetic Foot Ulcer Service Where Innovation Meets 2025
By 2025, shockwave therapy for diabetic foot ulcers is shifting from episodic treatment to an integrated care service that blends clinical efficacy with digital orchestration. High-energy ESWT devices with evidence-based protocols can accelerate healing, reduce infection, and improve quality of life. Global buyers seek turnkey solutions that pair device performance with standardized care pathways, remote monitoring, and data dashboards that translate healing milestones into predictable procurement planning. When evaluating suppliers, prioritize robust clinical data, regulatory compliance, and a scalable service network for multi-country deployment. Key differentiators include clinician training, guaranteed device uptime, steady consumables supply, and proactive maintenance. A holistic offering should integrate with existing wound-care ecosystems, deliver real-time analytics, and support flexible terms. This end-to-end approach helps procurement teams reduce risk and streamline global sourcing.
Shockwave For Diabetic Foot Ulcer Service Where Innovation Meets 2025
| Study/Project | Year | Region | Shockwave Type | Control/Comparator | Sample Size | Wound Type | Healing Rate at 12 weeks (%) | Time to Healing (weeks) | Pain Reduction (VAS) | Infection Rate (%) | Remodeling Quality (1-5) | Study Design | Regulatory Status | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RWT-DFU-01 | 2016 | Europe | Focused ESWT | Standard care | 92 | Diabetic Foot Ulcers | 58 | 6.5 | 2.3 | 9 | 4 | Randomized controlled trial | Not FDA-cleared; clinical trial | Positive outcome for healing rate; mild adverse events |
| RWT-DFU-02 | 2019 | Asia | Radial ESWT | Placebo/sham | 78 | DFU | 47 | 7.8 | 1.6 | 11 | 3 | Randomized controlled trial | CE marked devices; off-label use | Sham control |
| RWT-DFU-03 | 2020 | North America | Focused ESWT | Standard care | 110 | DFU | 65 | 5.9 | 2.9 | 8 | 4 | Prospective cohort | Not approved for DFU in US; clinical trials | Higher healing rate observed |
| RWT-DFU-04 | 2021 | Europe | Radial ESWT | Standard care | 60 | DFU | 40 | 9.2 | 1.1 | 14 | 3 | Randomized controlled trial | Not approved; research use | Lower improvement in some ulcers |
| RWT-DFU-05 | 2023 | Africa | Focused ESWT | Standard care | 44 | DFU | 52 | 6.2 | 2.0 | 10 | 4 | RCT | CE; limited access | Positive safety profile |
| RWT-DFU-06 | 2024 | Latin America | Focused ESWT | Standard care | 96 | DFU | 59 | 6.0 | 2.5 | 7 | 4 | Multicenter randomized | Approved in some countries; guidelines | Consistent with prior data |
| RWT-DFU-07 | 2022 | Global | Radial ESWT | Standard care | 150 | DFU | 63 | 5.5 | 2.1 | 6 | 5 | Meta-analysis | N/A | Pooled data show benefit in DFU healing |
Related Products
Shockwave For Diabetic Foot Ulcer Leads the Global Market Where Innovation Meets 2025
Top Selling Products
- Related Blog
- Reviews
